Aptivus

Active Ingredient(s): Tipranavir
FDA Approved: * June 22, 2005
Pharm Company: * BOEHRINGER INGELHEIM
Category: HIV / AIDS

Tipranavir (TPV), or tipranavir disodium, is a nonpeptidic protease inhibitor (PI) manufactured by Boehringer Ingelheim under the trade name Aptivus /æptvs/ AP-tiv-s. It is administered with ritonavir in combination therapy to treat HIV infection. Tipranavir has the ability to inhibit the replication of viruses that are resistant to other protease inhibitors and it recommended for patients who are resistant to other treatments. Resistance to tipranavir itself seems to require multiple mu... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Aptivus TPV;250
Aptivus 250 mg Oral Capsule
NDC: 0597-0003
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
Aptivus 100 mg/ml Oral Solution
NDC: 0597-0002
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.